Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- BalstilimabAGEN2034Phase 23 trials
ImmunoGenesis · Metastatic Prostate Cancer, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Cancer
- BoserolimabMK-5890Phase 23 trials
Merck & Co. · Carcinoma, Non-Small-Cell Lung, Small Cell Lung Cancer
- BrogidirsenNS-089, NCNP-02Phase 23 trials
NS Pharma, Inc. · Duchenne Muscular Dystrophy, Exon 44, DMD
- BT5528nuzefatide pevedotinPhase 23 trials
BicycleTx Limited · Advanced Solid Tumors, Advanced Solid Tumor Historically Known for High EphA2 Expression, Urothelial Cancer
- BudoprutugTNT119Phase 23 trials
Climb Bio, Inc. · Primary Membranous Nephropathy, Systemic Lupus Erthematosus, Immune Thrombocytopenia (ITP)
- CBP-0276Phase 23 trials
Clarent Biopharma, Inc. · Psoriasis, Arthritic Psoriasis, Hip or Knee Replacement
- CID-103Phase 23 trials
CASI pharmaceuticals, Inc. · Chronic Immune Thrombocytopenia, Antibody Mediated Rejection
- DDY391Phase 23 trials
Novartis · Moderate to Severe Psoriatic Arthritis, Sjögren's Disease
- Dihuang Baoyuan Granulesprescription BPhase 23 trials
Beijing Supreme Life Pharmaceutical Technology Co., Ltd. · Diabetes Mellitus, Type 2, Diabetes, Type2diabetes
- ENV-294Phase 23 trials
Enveda Therapeutics · Atopic Dermatitis (AD), Atopic Dermatitis, Asthma
- ENX-102ENX-102 -dose, ENX-102 mid-dosePhase 23 trials
Engrail Therapeutics INC · General Anxiety Disorder, Social Anxiety Disorder (SAD), Generalized Anxiety Disorder
- ESG206ESG206-2Phase 23 trials
Shanghai Escugen Biotechnology Co., Ltd · Systemic Lupus Erythematosus (SLE), Immune Thrombocytopenia (ITP), Primary Sjögren Syndrome
- ETX101Phase 23 trials
Encoded Therapeutics · Dravet Syndrome
- Fuling Yunhua Granulesprescription APhase 23 trials
Beijing Supreme Life Pharmaceutical Technology Co., Ltd. · Diabetes Mellitus, Type 2, Diabetes, Type2diabetes
- GalvokimigUCB9741Phase 23 trials
UCB · Chronic Obstructive Pulmonary Disease With Chronic Bronchitis, Atopic Dermatitis, Non-cystic Fibrosis Bronchiectasis
- GenSci048Phase 23 trials
Changchun GeneScience Pharmaceutical Co., Ltd. · Uveitis, Systemic Sclerosis Associated Interstitial Lung Disease, Rheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD)
- GIA632Phase 23 trials
Novartis · Atopic Dermatitis, Non-segmental Vitiligo, Cutaneous Lichen Planus
- GSK4532990Phase 23 trials
GSK · Non-alcoholic Fatty Liver Disease, Liver Diseases, Alcoholic, Nonalcoholic Fatty Liver Disease
- GV20-0251Phase 23 trials
GV20 Therapeutics · Endometrial Carcinoma (EC), Squamous Head and Neck Carcinoma, pMMR/MSS Adenocarcinoma of the Colon or Rectum
- HRS-2189Phase 23 trials
Jiangsu HengRui Medicine Co., Ltd. · Advanced Unresectable or Metastatic Breast Cancer, Breast Cancer, Prostate Cancer
- HRS-4508Phase 23 trials
Jiangsu HengRui Medicine Co., Ltd. · Solid Tumor, Lung Cancer
- HRS-4729Phase 23 trials
Fujian Shengdi Pharmaceutical Co., Ltd. · Metabolic Dysfunction-Associated Steatohepatitis (MASH), Type 2 Diabetes, Overweight or Obesity
- HRS-5346MK-7262Phase 23 trials
Shandong Suncadia Medicine Co., Ltd. · Lipoprotein(a), Lipoprotein Disorder, Treatment of Lipoprotein Disorder
- HS_SW01 cellsHS_SW01Phase 23 trials
Shenzhen Huishan Biotechnology Co., Ltd. · Ankylosing Spondylitis, Primary Ovarian Insufficiency (Poi), Systemic Sclerosis (SSc)
- HSK39297 200mgQDPhase 23 trials
Haisco Pharmaceutical Group Co., Ltd. · IgA Nephropathy (IgAN), Lupus Nephritis (LN)
- HT-101Phase 23 trials
Suzhou HepaThera Biotech Co., Ltd. · Chronic Hepatitis B, Chronic Hepatitis B Virus Infection
- HT-102Phase 23 trials
Suzhou HepaThera Biotech Co., Ltd. · Chronic Hepatitis B, Chronic Hepatitis B Virus Infection
- Human Dopaminergic Progenitor CellsNouvNeu001Phase 23 trials
iRegene Therapeutics Co., Ltd. · Parkinson Disease, Parkinson Disease (PD)
- IAP0971Phase 23 trials
SUNHO(China)BioPharmaceutical CO., Ltd. · Advanced Malignant Neoplasm, Advanced or Metastatic Non-small Cell Lung Cancer, Bladder Cancer
- IMG-007Phase 23 trials
Inmagene LLC · Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema
- IMR-687Tovinontrine, CRD-750Phase 23 trials
Cardurion Pharmaceuticals, Inc. · Heart Failure, Cardiovascular Diseases, Heart Diseases
- INCAGN02385Phase 23 trials
Incyte · Melanoma, Endometrial Cancer, Head and Neck Cancer
- INCAGN02390Phase 23 trials
Incyte · Melanoma, Endometrial Cancer, Head and Neck Cancer
- INE963Phase 23 trials
Novartis · Uncomplicated Plasmodium Falciparum Malaria
- IPG11406Phase 23 trials
Nanjing Immunophage Biotech Co., Ltd · Lupus Nephritis, Moderately to Severely Active Ulcerative Colitis (UC)
- iPSChuman allogeneic induced pluripotent stem cell -derived dopaminergic neural progenitor cell, Allogeneic Human Induced Pluripotent Stem Cell -Derived Motor Neuron Progenitor CellsPhase 23 trials
XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. · Spinal Cord Injury, Safety, Efficacy
- JAB-23E73Phase 23 trials
Jacobio Pharmaceuticals Co., Ltd. · Advanced Solid Tumor, Advanced Solid Tumors, Metastatic Pancreatic Ductal Adenocarcinoma
- JDQ443OpnurasibPhase 23 trials
Novartis · Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation, Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung Cancer, Advanced Solid Tumors Harboring the KRAS G12C Mutation
- JPI-547Phase 23 trials
Onconic Therapeutics Inc. · Pancreatic Ductal Adenocarcinoma, Gastric Cancer (GC), Ovarian Cancer
- KT-621Phase 23 trials
Kymera Therapeutics, Inc. · Eosinophilic Asthma, Atopic Dermatitis, Asthma (Diagnosis)
- LT-002-158Phase 23 trials
Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. · Atopic Dermatitis (AD), Hidradenitis Suppurativa (HS)
- LT3001Phase 23 trials
Lumosa Therapeutics Co., Ltd. · Acute Ischemic Stroke
- Lu AG13909AsedebartPhase 23 trials
H. Lundbeck A/S · Cushing's Disease, Congenital Adrenal Hyperplasia, Adrenal Hyperplasia, Congenital
- LY4065967Phase 23 trials
Eli Lilly · Chronic Pain, Diabetic Peripheral Neuropathic Pain, Osteoarthritis, Knee
- MacupatideLY3532226Phase 23 trials
Eli Lilly · Obesity, Overweight, Diabetes Mellitus, Type 2
- MAR001Phase 23 trials
Marea Therapeutics · Hypertriglyceridemia
- MCLA-129Phase 23 trials
Betta Pharmaceuticals Co., Ltd. · Non-Small Cell Lung Cancer, Solid Tumor, Head and Neck Cancer
- mesenchymal stem cellumbilical cord derived MSCsPhase 23 trials
Cell Energy Life Sciences Group Co. LTD · AIDS, Ischemic Heart Disease, Osteoarthritis
- MHB036CPhase 23 trials
Minghui Pharmaceutical (Hangzhou) Ltd · Advanced Breast Cancer, Advanced Malignant Solid Tumor, Advanced Lung Cancer
- MK-0482Phase 23 trials
Merck & Co. · Carcinoma, Non-Small-Cell Lung
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.